AbbVie completed its cash acquisition of Apogee Therapeutics, adding late-stage and earlier-stage immunology assets while reaffirming its 2026 earnings outlook.

Campbell’s is resetting its quarterly payout to $0.25 a share and targeting $500 million in savings by fiscal 2030 after a year of weaker sales and margins.

Ciena posted record fiscal third-quarter revenue of $1.671 billion and lifted its full-year 2026 sales forecast as cloud-provider demand and AI-related network spending stayed strong.

Victoria’s Secret & Co. posted a 10.4% rise in second-quarter net sales and lifted its full-year forecast after adjusted operating income topped guidance.

Brady posted record fiscal 2026 revenue and adjusted EPS, while its fiscal 2027 outlook points to roughly 23% adjusted EPS growth at the midpoint as the new IPS segment enters the results.

Bank of England Chief Economist Huw Pill says a prompt rise to 4% could limit the risk that temporary inflation pressures become more persistent.

Japan’s latest 30-year bond auction cleared at a 4.079% average yield, with demand slightly softer than August as investors digested a sharp repricing in Japanese government bonds.

Updated terms and new Carabobo acreage support plans by Chevron’s Venezuelan joint ventures to invest more than $7 billion over five years and lift production to about 600,000 barrels a day.

CPP Investments will hold about 51% of the Nordic data-center operator, with Equinix at roughly 34% and Partners Group reinvesting for about 10%.

Vertiv agreed to pay about $1.45 billion in cash at closing for UtilityInnovation Group, with two performance-based earnout tranches that could add up to $1.15 billion.